Regulatory tracker

Daily aggregated filings from FDA, DEA, SEC, CMS, and the Federal Register, filtered for mental health relevance.

July 13, 2026
CT
Efficacy of a Gamified Blended Mindfulness Program to Reduce Burnout, Stress, and Anxiety in Nursing Students: A Randomized Controlled Trial
research

Burnout Syndrome, Psychological Stress, Anxiety, and Depression Associated With Academic Pressure, Anxiety — Psychoeducation and Free App Recommendation, Standard Blended Mindfulness Program, Gamified Blended Mindfulness Program

View on ClinicalTrials.gov
CT
Prevention of Burnout in Spanish Healthcare Professionals Through Attachment-Based Compassion Therapy (ABCT)
research

Burnout Syndrome, Anxiety Depression, Stress — Attachment-based compassion therapy Compassion, Relaxation program

View on ClinicalTrials.gov
CT
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
research

Bipolar Depression Depressed Phase, Obesity & Overweight — Lumateperone 42 mg

View on ClinicalTrials.gov
CT
Effect of Patient Anxiety Level Prior to Undergoing ERCP and Procedure Tolerability and Outcomes.
research

Anxiety, Biliary and Pancreatic Diseases, ERCP — Not applicable- observational study

View on ClinicalTrials.gov
CT
Two-Year Follow-up Study on Children Exposed to Trauma
research

Post-traumatic Stress Disorder (PTSD), Complex Post-Traumatic Stress Disorder (CPTSD)

View on ClinicalTrials.gov
CT
Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use
research

Nicotine Dependence — Oral Nicotine Pouch, Smoking Cue Reactivity Task

View on ClinicalTrials.gov
CT
Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking
research

Sex Trafficking, HIV, Substance Use (Drugs, Alcohol), Mental Health, Sexual Violence, Treatment Engagement — CONNECT

View on ClinicalTrials.gov
CT
Craving Management Program for Substance Use Disorders
research

Substance Use Disorder (SUD) — Craving Management and Alternative Behavior Enhancement Program

View on ClinicalTrials.gov
CT
Developing and Strengthening Cannabis Warnings: Warning Message Testing
cannabis · research

Cannabis, Marijuana Use — Constituents, Cognitive Functioning, Cardiovascular Health

View on ClinicalTrials.gov
CT
Emotion Regulation Program for Substance Use Disorders
research

Substance Use Disorder (SUD) — Emotion Regulation Program

View on ClinicalTrials.gov
CT
ExMI vs. Biofeedback PFMT for Post-Prostatectomy Incontinence
research

Post-Prostatectomy Urinary Incontinence, Benign Prostatic Hyperplasia — Extracorporeal Magnetic Stimulation (ExMI), Pelvic Floor Muscle Training (PFMT)

View on ClinicalTrials.gov
July 10, 2026
CT
Evaluation of Alexithymia in Chronic Pain Patients With Spinal Cord Stimulation
research

Chronic Pain — Psychometric Questionnaires and Retrospective Data Collection

View on ClinicalTrials.gov
CT
Cannabidiol Oil for Treatment-Resistant Major Depression
cannabis · research

Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD) — Full-spectrum CBD oil 100 mg/mL, Placebo oil (MCT oil)

View on ClinicalTrials.gov
CT
Stress Ball and Video Distraction During Pediatric Enema
research

Constipation - Functional, Abdominal Distension — Stress Ball, Video Distraction

View on ClinicalTrials.gov
CT
Immersive VR to Reduce Stress, Anxiety, and Pain During PICC/Midline Placement
research

Vasoconstriction, Biomarkers, Central Venous Catheters, Midline Catheter, Pain, Anxiety, Catheterization, Peripheral Venous Catheterization, Stress (Psychology) — Immersive Virtual Reality, Peripherally Inserted Central Catheter (PICC), Mepivacaine 2% Injection

View on ClinicalTrials.gov
CT
Interoceptive Awareness, Perceived Stress, and Physical Performance in Sport Sciences Students
research

Interoception, Perceived Stress, Anxiety, Sleep Quality, Physical Performance, Athletic Performance — Psychological and Physical Performance Assessment Battery

View on ClinicalTrials.gov
CT
The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction
research

Myocardial Infarction — virtual reality glasses

View on ClinicalTrials.gov
CT
Mobile Video Education and Machine Learning-Based Risk Prediction in Neonatal Seizure Management
research

Seizure Recurrence — Mobile Video-Supported Education

View on ClinicalTrials.gov
CT
Effect of Music and Lighting on Anxiety During Urodynamic Study
research

Lower Urinary Tract Symptoms, Urinary Incontinence, Voiding Dysfunction — Standard Lighting, music, Dim lighting

View on ClinicalTrials.gov
CT
"The Effect of AI-Assisted Mobilization Education on Kinesiophobia and Readiness for Hospital Discharge in Patients Undergoing Total Knee Arthroplasty''
research

Total Knee Anthroplasty — Artificial intelligence-assisted mobilization education video

View on ClinicalTrials.gov
CT
Operation Calm: VR Nature-Based Mindfulness to Reduce Pediatric Surgical Anxiety
research

Preoperative Anxiety Experienced by the Pediatric Patient — Operation Calm EEMCF-VR

View on ClinicalTrials.gov
CT
Virtual Reality and Cryotherapy for Postoperative Pain and Anxiety After Cesarean Section
research

Postoperative Pain, Anxiety, Cesarean Section Complications — Virtual Reality, Cryotherapy

View on ClinicalTrials.gov
CT
Digital Technology Use, Digit Ratio, and Handgrip Strength in University Students
research

Problematic Smartphone Use, Internet Addiction, Healthy Volunteers

View on ClinicalTrials.gov
CT
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
cannabis · research

Cannabis Use, Tobacco, Biomarkers — Cannabis (THC), Tobacco Cigarette

View on ClinicalTrials.gov
CT
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
research

Tobacco Use Cessation, Tobacco Use Disorder, Nicotine Dependence, Smokeless Tobacco Use — QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT)

View on ClinicalTrials.gov
CT
Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse
research

Substance Use, Children, Cultural Factors — Returning to the Land - Biodiverse Outdoor Setting, Control

View on ClinicalTrials.gov
CT
The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy
research

Schizophrenia / Schizoaffective Disorder — Modification Diet, Hospitalized Diet

View on ClinicalTrials.gov
July 9, 2026
DEA
Designation of Phenethyl Halides as List I Chemicals
scheduling

The Drug Enforcement Administration is proposing the control of phenethyl halides as list I chemicals under the Controlled Substances Act (CSA). Phenethyl halides are important to the illicit manufacture of fentanyl, as well as fentanyl analogues, and fentanyl- related substances

View on Federal Register
CT
Repeated Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression
research

Major Depressive Disorder (MDD) — Active Biofeedback, Sham Biofeedback

View on ClinicalTrials.gov
CT
Mindfulness for Emotional Distress: Neural Mechanisms
research

Emotional Distress, Anxiety, Depression, Stress (Psychology), Psychological — MIED, PMR

View on ClinicalTrials.gov
CT
The Effect Of Postpartum Therapeutıc Touch On Breastfeedıng Self-Effıcacy, Maternal Attachment, And Postpartum Depressıon In Prımıparous Women: A Randomızed Controlled Study
research

Breastfeeding Self-efficacy, Maternal Attachment — therapeutic touch, terapötik dokunma

View on ClinicalTrials.gov
CT
Effect of Psychobiotics With Standard Antiddepressants in Treatment of Major Depressive Disorder
research

Major Depression — Lactobacillus Helveticus and bifidobacterium Longum, Placebo Capsule(s)

View on ClinicalTrials.gov
CT
Multisensory Interventions Reduce MRI Anxiety in Cancer Patients
research

Malignant Tumor (Cancer), MRI Examination-induced Anxiety — Guzheng music therapy, Lavender aromatherapy

View on ClinicalTrials.gov
CT
Anxiety in Children and Families During MRI Under Anesthesia
research

Mental Health, Anxiety — Multi-modal Psychological Preparation

View on ClinicalTrials.gov
CT
The Effect of Progressive Muscle Relaxation Exercise Applied Before Endometrial Biopsy on Pain, Anxiety Level and Patient Comfort in Premenopausal Women
research

Endometrial Diseases — progressive muscle relaxation exercise

View on ClinicalTrials.gov
CT
The BARBER Trial: Music and Binaural Beats During Prostate Biopsy
research

Pain, Anxiety, Prostate Biopsy — Binaural beats auditory intervention, Classical music auditory intervention, No Music Group

View on ClinicalTrials.gov
CT
Evaluation of Virtual Reality Based Distraction on Anxiety and Pain Perception in Paediatric Dental Extraction
research

Dental Anxiety in Children, Pain Perception — Virtual reality headset, Audio-visual distraction with 2D cartoons, Tell-show-do with verbal distraction

View on ClinicalTrials.gov
CT
Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients
research

Pain, Procedural (During Sternum Dressing on Infants), Arteriovenous Fistula, Kidney Failure, Chronic — Usual Care (Room-Temperature Water Bag), Cryotherapy (Ice Pack), Lidocaine/Prilocaine Gel

View on ClinicalTrials.gov
CT
The Effect of Animated Videos and Therapeutic Play Methods on Emotional Expression, Fear and Anxiety in Children Aged 4-8 Years During the Throat Swab Procedure
research

Taking a Throat Swab — Animation video, Therapeutic Play

View on ClinicalTrials.gov
CT
Cognitive Training for Functioning in PTSD
research

Posttraumatic Stress Disorder — COGENT (Cognitive ENhancement Training), ST (Sham Training)

View on ClinicalTrials.gov
CT
Intermittent Theta-Burst Stimulation (iTBS) as an add-on to Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Post-traumatic Stress Disorder (PTSD)
research

PTSD - Post Traumatic Stress Disorder — Intermittent Theta-Burst Stimulation (iTBS)

View on ClinicalTrials.gov
CT
The Effect of Comorbid Alcohol/Substance Use
research

Alcohol Abuse, Alcohol Use Disorder, Substance Use Disorders, Severe Mental Disorder, Schizophrenia, Bipolar Disorder, Ostracism — case (comorbid diagnosis), control

View on ClinicalTrials.gov
CT
Implementing DBT in Short-Term SUD-treatment
research

Substance Abuse Disorder, Dialectical Behavior Therapy, Emotion Management Skills — DBT-informed milieu therapy, Treatment as usual

View on ClinicalTrials.gov
CT
Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
research

Opioid Use Disorder, Opioid Consumption, Persistent Opioid Use, Persistent Postsurgical Pain

View on ClinicalTrials.gov
July 8, 2026
DEA
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
scheduling

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever th

View on Federal Register
CT
Narrative Therapy for Anxiety and Depression in Palestinian Refugee Adolescents
research

Anxiety, Depression - Major Depressive Disorder — Culturally Adapted Narrative Therapy

View on ClinicalTrials.gov
CT
Eye-tracking Training for Older Adults
research

Subjective Memory Complaints, Anxiety — Eye-Tracking Training

View on ClinicalTrials.gov
CT
An Ecological Momentary Assessment Based Program to Support Self-Management for Post-stroke Patients
research

Stroke, Post Stroke — Ecological Momentary Assessment based Self-management Program

View on ClinicalTrials.gov
CT
Buzzy® and Cognitive Behavioral Intervention Package During Blood Draw in Children
research

Procedural Pain, Procedural Fear, Procedural Anxiety — Cognitive Behavioral Intervention Package, Buzzy®

View on ClinicalTrials.gov
CT
VR Effects After Hip Replacement Surgery Pain
research

Virtual Reality, Hip Arthropathy, Comfort, Anxiety, Pain, Postoperative — cognitive intervention

View on ClinicalTrials.gov
CT
The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder
research

Tiletamine Use Disorder, Substance Use Disorder (SUD), Drug Craving — Transcutaneous Auricular Vagus Nerve Stimulation, Sham Stimulation

View on ClinicalTrials.gov
CT
Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal
research

Cognitive Cycling, Alcohol Use Disorder (AUD), Treatment — cognitive cycling

View on ClinicalTrials.gov
CT
Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)
research

SCHIZOPHRENIA 1 (Disorder) — Cariprazine Hard Capsules, Reagila® Hartkapseln (Hard Capsules) (Cariprazine)

View on ClinicalTrials.gov
July 7, 2026
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC.
scheduling

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
CT
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
research

Perimenopause, PMDD — transcutaneous auricular neurostimulation (tAN)

View on ClinicalTrials.gov
CT
Feasibility and Effects of a Blended Baduanjin Exercise and Green Tea Consumption Program on Depressive Symptoms, Gut Microbiota and Quality of Life in Older Adults
research

Depressive Symptoms — blended Baduanjin and Green Tea consumption program, Non-treatment control

View on ClinicalTrials.gov
CT
To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.
research

Premenstrual Dysphoric Disorder ( PMDD)

View on ClinicalTrials.gov
CT
Suvorexant 3 - PE-PC
research

PTSD - Post Traumatic Stress Disorder, Insomnia, TBI (Traumatic Brain Injury) — Suvorexant, Placebo, Prolonged Exposure Therapy for Primary Care (PE-PC)

View on ClinicalTrials.gov
CT
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
research

Schizophrenia — Xanomeline/Trospium Chloride, Placebo

View on ClinicalTrials.gov
July 6, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and sa

View on Federal Register
DEA
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever th

View on Federal Register
CT
Email-Delivered Digital Positive Affect Intervention for Young Adults in Zimbabwe
research

Depression Symptoms — Email-Delivered Positive Affect Intervention, Psychoeducational Control

View on ClinicalTrials.gov
CT
Pregnenolone for Cannabis Use Disorder and Depression
cannabis · research

Cannabis Use Disorder, Major Depressive Disorder (MDD) — Pregnenolone

View on ClinicalTrials.gov
CT
Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries
research

Pregnancy Loss, Early, Major Depression, Anxiety, Stress (Psychology) — COPL participation

View on ClinicalTrials.gov
CT
Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
research

Depression, Anxiety, Heart Injuries — Diagnostic Test: 18F-AIPFA-1026

View on ClinicalTrials.gov
CT
Oral and Sublingual Ketamine
pharma · research

Major Depression Severe — 75 mg of oral ketamine, Sublingual ketamine 75 mg

View on ClinicalTrials.gov
CT
Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea
research

Primary Dysmenorrhea (PD), Primary Dysmenorrhea — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Sham transcutaneous auricular vagus nerve stimulation

View on ClinicalTrials.gov
CT
Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers
research

Depression - Major Depressive Disorder, Depression Bipolar, Depression Unipolar — Repetitive transcranial magnetic stimulation

View on ClinicalTrials.gov
CT
Intern Health Study 2026
research

Depression / Major Depressive Disorder, Mood, Sleep, Physical Activity — Intern Health Study behavioral change mobile notification

View on ClinicalTrials.gov
CT
Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity
research

PTSD (Childbirth-Related), Severe Maternal Morbidity, Depression - Major Depressive Disorder, Anxiety — Virtual maternal fetal medicine debriefing consult

View on ClinicalTrials.gov
CT
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance
research

Major Depressive Disorder (MDD) — Motif XCS System

View on ClinicalTrials.gov
CT
Effect of Cognitive Behavioral Based Psychoeducation Program on Internet Addiction and Academic Procrastination Tendency in Nursing Students
research

Internet Addiction, Procrastination — Cognitive Behavioral Approach-Based Psychoeducation Program

View on ClinicalTrials.gov
CT
Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD)
research

Substance Use Disorder (SUD) — Next Generation Dome Helmet (NGDH)

View on ClinicalTrials.gov
CT
Investigation of the Effects of Angling as Supportive Therapy in Schizophrenia Treatment on Serum Parameters, Anxiety, Depression, and Quality of Life
research

Angling, Supportive Therapeutic, Schizophrenia — recreational fishing (angling)

View on ClinicalTrials.gov
July 2, 2026
CT
CBITS-RTM Pilot Study
research

PTSD - Post Traumatic Stress Disorder, Substance Use — Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM)

View on ClinicalTrials.gov
CT
Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms
research

PTSD, Cognitive Performance — Cognitive Processing Therapy, Eye-Movement Desensitization and Reprocessing

View on ClinicalTrials.gov
CT
Accelerated iTBS for PTSD and Depression
research

Post Traumatic Stress Disorder PTSD, Major Depressive Disorder (MDD) — Accelerated intermittent theta burst stimulation

View on ClinicalTrials.gov
CT
Effects of Nimodipine on Alcohol Drinking
research

Alcohol Use Disorder — Nimodipine, Placebo

View on ClinicalTrials.gov
CT
Biomarker-Guided Antidepressant Selection
pharma · research

Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD), rTMS, Ketamine, fMRI — TMS, Ketamine

View on ClinicalTrials.gov
CT
Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
research

Schizophrenia — TES-TI, Sham TES-TI

View on ClinicalTrials.gov
CT
Combining HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia
research

Negative Symptoms in Schizophrenia, Brain Stimulation Intervention — active iTBS followed by active HD-tDCS, active iTBS followed by sham HD-tDCS, sham iTBS followed by active HD-tDCS

View on ClinicalTrials.gov
CT
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
research

Schizophrenia — Ublituximab

View on ClinicalTrials.gov
CT
Neuromodulation of Mood Switch Circuitry in Bipolar Disorder
research

Bipolar Disorder (BD), Bipolar 1 Depression, rTMS, fMRI — MagVenture MagPro TMS system, Sham Stimulation

View on ClinicalTrials.gov
July 1, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro- 2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-1496

View on Federal Register
CT
Effects of a 12-Week Structured Badminton Intervention on Smartphone Addiction Among Adolescents
research

Smartphone Addiction Level — 12-Week Structured Badminton Program

View on ClinicalTrials.gov
CT
Pomegranate Dietary Supplements in AUD and ALD
research

Alcohol Use Disorder, Alcohol-associated Liver Disease, Alcoholic Cirrhosis, Healthy — Pomegranate Dietary Ssupplement

View on ClinicalTrials.gov
CT
Type D Personality and Life Satisfaction in Bipolar Disorder Type 2 and Major Depressive Disorder
research

Bipolar Disorder II, Major Depressive Disorder (MDD)

View on ClinicalTrials.gov
June 30, 2026
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
scheduling

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
scheduling

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
scheduling

Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
scheduling

Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
scheduling

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
FDA
Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation

The Food and Drug Administration (FDA) is classifying the monitor for opioid induced impairment of oxygenation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classific

View on Federal Register
CT
Efficacy of a Fully Automated Electronic Screening and Brief Intervention to Reduce Harmful Alcohol Consumption: A Randomized Clinical Trial
research

Binge Drinking, Harmful Use of Alcohol — screening and brief intervention, electronic screening and brief intervention tool (e-SBI) for reducing rate of harmful alcohol consumption (HAC)

View on ClinicalTrials.gov
CT
Preventing Harmful Alcohol Use Among Trauma Patients in Cameroon
research

Alcohol Use Disorder, Alcohol-Related Injury, Trauma — Cameroon-Adapted SBIRT, Usual Care

View on ClinicalTrials.gov
CT
A Cognitive Mobile Intervention for Motivation in Psychotic Disorders
research

Schizophrenia / Schizoaffective Disorder — Cognitive Training, Mobile cognitive training

View on ClinicalTrials.gov
CT
This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects.
research

Bipolar 1 Depression — Lumateperone, Cariprazine

View on ClinicalTrials.gov
June 29, 2026
CT
EMDR Flash Group Protocol for Earthquake Survivors
research

Post-traumatic Stress Disorder (PTSD), Acute Stress Disorder, Anxiety, Depression — EMDR Flash Group Protocol

View on ClinicalTrials.gov
CT
Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT
research

Prevention, Substance Use, Refugee Health — Acceptance and Commitment Therapy, Attention Control

View on ClinicalTrials.gov
CT
Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression
research

Treatment-resistant Depression (TRD), Major Depression — Intermittent Theta Burst Stimulation (iTBS)

View on ClinicalTrials.gov
CT
α-N-acetylgalactosaminidase in Schizoaffective Disorder
research
June 26, 2026
CT
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
research

Post Traumatic Stress Disorder — TSND-201

View on ClinicalTrials.gov
CT
SEEG-Guided DBS for Schizophrenia
research

Schizophrenia Disorders, Schizo Affective Disorder — SEEG implantation, Deep brain stimulation

View on ClinicalTrials.gov
CT
A Pilot Study of Adjunctive Structured Supportive Psychotherapy in Schizophrenia
research

Schizophrenia, Cognitive and Executive Dysfunction, Neuroinflammation — Structured supportive psychotherapy, Risperidone, Unstructured Supportive Conversation

View on ClinicalTrials.gov
June 25, 2026
CT
The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
research

Post Traumatic Stress Disorder PTSD — Sleep Profiler Headband

View on ClinicalTrials.gov
CT
Cannabis Effects on Opioid Self-Administration
cannabis · research

Opioid Use Disorder, Cannabis Use — Cannabis, Placebo Cannabis, Intranasal Opioid Agonist

View on ClinicalTrials.gov
CT
Effects of Olfactory Stimuli in Virtual Reality Cue Exposure on Craving and Attentional Bias in Alcohol Use Disorder
research

Alcohol Use Disorder — VR-CE

View on ClinicalTrials.gov
June 24, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol), including its isomers, es

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
scheduling

On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such

View on Federal Register
CT
Effects of Stimulant Medications in PTSD
research

Adderall, PTSD, Post Traumatic Stress Disorder — Placebo, Adderall

View on ClinicalTrials.gov
CT
Pre-Pilot WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD
research

Opioid-Related Disorders, Substance-Related Disorders, Intimate Partner Violence (IPV), Stress Disorders, Post-Traumatic, Domestic Violence, Medication for Opioid Use Disorder (MOUD), Post Traumatic Stress Disorder PTSD — Pre-Pilot WINGS++++

View on ClinicalTrials.gov
CT
Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression
research

Bipolar Disorder (BD) — Pramipexole, Placebo

View on ClinicalTrials.gov
CT
Risperidone vs Cariprazine in Acute Mania
research

Bipolar 1 Disorder — Risperidone, Cariprazine

View on ClinicalTrials.gov
June 23, 2026
CT
4-STEP-Training Program for Doomscrolling, Cyberchondriac Behavior and Psychiatric Symptoms (4-STEP-TPS) Among Individuals With Social Media Addiction
research

Doomscrolling, Cyberchondriac Behavior, Social Media Addiction — 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS)

View on ClinicalTrials.gov
CT
Mobile Restriction on Dopamine Transporter
research

Addiction, SMARTPHONE OWNER — Mobile phone restrction

View on ClinicalTrials.gov
June 22, 2026
CT
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
cannabis · psychedelics · research

Asperger's Disorder, Asperger Disorder, Autism Disorder, Autism, ADHD - Attention Deficit Disorder With Hyperactivity, ADHD, ASD, Alcohol Abuse/Dependence, Alcohol Addiction, Alcohol and Other Drug Use Disorders, Alcohol and Other Substance Use Prevention, Gambling Addiction, Gam

View on ClinicalTrials.gov
CT
Cannabis and Opioid Use Disorder, Study 2
cannabis · research

Opioid Use Disorders, Cannabis Use — Inhaled Cannabis, Intranasal Opioid

View on ClinicalTrials.gov
CT
dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia
research

Schizophrenia Disorder — Temporal Interference Stimulation, Sham Temporal Interference Stimulation

View on ClinicalTrials.gov
CT
The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia
research

SCHIZOPHRENIA 1 (Disorder) — Acceptance and Commitment Therapy (ACT)-Based Nursing Intervention

View on ClinicalTrials.gov
CT
Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia
research

Schizophrenia, Schizoaffective — Frontal gamma coherence neurofeedback, Placebo Neurofeedback

View on ClinicalTrials.gov
CT
Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.
research

Mental Health Promotion — School-Based Mental Health Programme

View on ClinicalTrials.gov
CT
Optimizing CBSST With Executive Function Training for Schizophrenia (R33)
research

Schizophrenia, Schizoaffective Disorder — E-CBSST, E-SC

View on ClinicalTrials.gov
June 18, 2026
CT
Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers
research

Posttraumatic Stress Disorder, Burns, Traumatic Injury, Acute Stress Disorder, Trauma and Stressor Related Disorders, Trauma and Stress Related Disorders, Stress Disorder, Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Stress Disorders, Traumatic, Acute, Relations

View on ClinicalTrials.gov
CT
Exposure by Assessment: Effects of Daily AMQ-Based EMA of an Intrusive Trauma Memory in PTSD
research

PTSD — AMQ-based ecological momentary assessment of an intrusive memory, AMQ-based ecological momentary assessment of an emotionally neutral memory

View on ClinicalTrials.gov
CT
Theory of Planned Behavior-Based Digital Addiction and Screen Time Management Training for Teachers
research

Digital Addiction and Screen Time Management Among Teachers — Digital Addiction and Screen Time Management Training Based on the Theory of Planned Behavior, Control group

View on ClinicalTrials.gov
CT
LaunchPad: Supporting Healthy Decisions and Preventing Drug Use After High School
cannabis · research

Substance-related Disorders, Alcohol-Related Disorders, Tobacco Use Disorder, Marijuana Use — Introduction, Norms re: Protective Behavior Strategies (PBS), Life Skills

View on ClinicalTrials.gov
CT
ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
research

SCHIZOPHRENIA 1 (Disorder) — Acceptance and Commitment Therapy (ACT)-Based Psychoeducation Program

View on ClinicalTrials.gov
CT
Exploring the Genetics of Schizophrenia in Manitoba
research

Schizophrenia, Healthy (Controls)

View on ClinicalTrials.gov
June 17, 2026
FDA
Andrew Jonathan Morgan: Final Debarment Order
scheduling

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Andrew Jonathan Morgan for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order

View on Federal Register
DEA
Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
scheduling

Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
scheduling

Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
CT
Hybrid Dialectical Behavior Therapy for Veterans to Further Reduce Emotion Regulation Problems and Trauma Symptoms
research

PTSD, Emotion Regulation Disorders, Substance Abuse — Hybrid dialectical behavior therapy

View on ClinicalTrials.gov
CT
Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia
research

Schizophrenia Disorder — Placebo, Sulforaphane

View on ClinicalTrials.gov
CT
Efficacy and Mechanism of IPSRT for Bipolar II Disorder
research

Bipolar Disorder II — Quetiapine (drug), Psychopharmacological treatment

View on ClinicalTrials.gov
June 16, 2026
CT
Non-Coding RNAs Gene Expression in Psychiatric Disorders
research

Schizophrenia Disorders, Major Depression, Bipolar Affective Disorders, Obsessive Compulsive Disorder (OCD), Anxiety Disorder (Panic Disorder or GAD) — Reverse Transcription Quantitative Polymerase Chain Reaction

View on ClinicalTrials.gov
June 15, 2026
CT
TIS for Improving Cognitive Impairment in Schizophrenia
research

Schizophrenia Disorder, Cognitive Impairments — temporal interference stimulation, Sham stimulation

View on ClinicalTrials.gov
CT
Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia
research

Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Ejaculatory Dysfunction — Water Vapor Thermal Therapy, Ejaculation-Sparing Bipolar Transurethral Enucleation of the Prostate

View on ClinicalTrials.gov